What are the payment terms accepted?

We accept LC, T/T, D/P, PayPal, Western Union, and small-amount payments.

What is the lead time for production?

The average lead time is within 15 workdays for both peak and off-peak seasons.

Is the product safe for consumption?

Yes, it meets strict standards for heavy metals, pesticides, and microbiological analysis, and is generally well-tolerated.

Hot Selling Wholesale EU Organic Artemisinin Tablet

Name: Hot Selling Wholesale EU Organic Artemisinin Tablet
Brand: Xi an Sost Biotech Co., Ltd.
SKU: 1909648795

Shaanxi, ChinaXi an Sost Biotech Co., Ltd.

US$10.00-200.00

1 kg

Product profile

Customization

Available

Certification

USDA Organic/EU Organic/ISO/Kosher/Halal/FDA

Assay Method

HPLC, UV

Model NO.

Artemisinin Tablet

Application Form

Tablet, Capsule, Powder

Application

Food, Health Care Products, Medicine

State

Powder

Extract Source

Stem Leaf

Product Name

Artemisinin Tablet

Appearance

White Powder

Latin Name

Artemisia annua L.

Active Ingredient

Artemisinin

Sample

Available

Stock

In Stock

Shelf Life

24 Months

COA

Available

Transport Package

Aluminum Foil Bag/Drum

Specification

Artemisinin 98% - 99%

Trademark

SOST

Origin

China

Production Capacity

1000 Tons/Day

Key features

Multi-Certification Compliance: Certified by USDA Organic, EU Organic, ISO, Kosher, Halal, and FDA standards.

High Purity Artemisinin: Assay result 98.32% via HPLC, ensuring high quality and potency.

OEM/ODM Customization: Supports OEM and ODM services with custom product naming and packaging.

Versatile Applications: Suitable for pharmaceuticals, health care products, and medicine forms.

Rapid Anti-Malarial Action: Possesses the most rapid action against falciparum malaria among current drugs.

Multiple Health Benefits: Used for anti-inflammatory, cancer relief, cough reduction, and blood pressure control.

Flexible Logistics Options: Offers Express, Air, and Sea shipping tailored to order volume and urgency.

Established Manufacturer: Factory established in 2012 with 53 employees and 2 R&D engineers.

Company profile

Xi an Sost Biotech Co., Ltd.

Shaanxi, China

CertifiedBusiness Type: Manufacturer/Factory CertifiedR&D Capacity: ODM Service Available & OEM Service AvailableExport Year: 2012-11-01 CertifiedNearest Port: Shanghai PortAverage Response Time: ≤3.04h CertifiedTerms of Payment: LC, T/T, D/P, etc.

AI-Powered supplier vetting

SummaryXi'an Sost Biotech Co., Ltd. is identified as a China-based manufacturer and trading company focused on herbal extracts, Chinese medicine raw materials, cosmetic ingredients, healthcare ingredients, food additives, and dietary supplement ingredients. Evidence indicates established production, R&D, sales, purchasing, and quality-control functions, with stated GMP-oriented operations, ISO 9001:2015 certification, multiple production bases, and broad export coverage. However, the records contain conflicting production information: one slice reports three production bases and eight lines, while another reports a 2,990 m² plant and two production lines. The supplier states that it provides pre- and after-sales service and accepts several trade and payment terms, but detailed service performance, customization results, customer references, and financial strength are not sufficiently documented. Monetary figures are omitted.

Supplier typeThe supplier is explicitly classified as a manufacturer and limited company, while another record identifies its business nature as a trading company. Its stated activities include R&D, production, sales, and service of herbal extracts and natural raw materials, so it appears to combine manufacturing and trading functions.

CertificationsThe supplier reports ISO 9001:2015 certification and states that production follows national GMP standards, with GMP-standard factories and 100,000-level clean workshops. ISO certification is explicit; the GMP statements are operational claims rather than a separately named certificate.

After-Sales capabilityThe company explicitly emphasizes before-sales and after-sales service, states that it continuously improves service, and describes service as part of its business operations. However, no evidence gives measurable after-sales performance, service staffing, response times, or documented customer outcomes.

R&D capabilityThe supplier reports an R&D department, research and development of high-purity natural products, biological engineering and natural extraction technology, and an innovation-oriented approach. Nevertheless, only two years of R&D engineer experience are reported, and there is no evidence of patents, new-product records, or quantified R&D achievements.

Production capacityProduction capability is supported by a stated manufacturing plant, natural-extract production activities, GMP-oriented facilities, clean workshops, and product lines covering food, healthcare, cosmetics, and pharmaceutical intermediates. The data are inconsistent: one record states three production bases and eight lines, while another reports a 2,990 m² plant and two lines; quality-control staffing is also reported as fewer than five employees.